N. Sakunrangsit

High phosphate intake induces bone loss in nephrectomized thalassemic mice

M. Greenblatt, S. Lotinun, S. Svasti, 2022, PloS one.

Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model

M. Greenblatt, S. Lotinun, Sarinya Kumpunya, 2021, PloS one.

NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.

A. Mutirangura, N. Sakunrangsit, Nalinee Pradubyat, 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer

S. Manmuan, N. Sakunrangsit, W. Ketchart, 2017, Clinical and experimental pharmacology & physiology.

Plumbagin Enhances Tamoxifen Sensitivity and Inhibits Tumor Invasion in Endocrine Resistant Breast Cancer through EMT Regulation

T. Pisitkun, N. Sakunrangsit, W. Ketchart, 2016, Phytotherapy research : PTR.

Plumbagin inhibited AKT signaling pathway in HER-2 overexpressed-endocrine resistant breast cancer cells.

N. Sakunrangsit, W. Ketchart, 2019, European journal of pharmacology.

Identification of candidate regulators of mandibular bone loss in FcγRIIB-/- Mice

M. Greenblatt, S. Lotinun, P. Prombutara, 2021, Scientific Reports.

Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt/β-catenin pathway in endocrine resistant breast cancer.

N. Sakunrangsit, W. Ketchart, 2019, Pharmacological research.

Accelerated Bone Loss in Transgenic Mice Expressing Constitutively Active TGF-β Receptor Type I

M. Greenblatt, S. Lotinun, A. Leelahavanichkul, 2023, International journal of molecular sciences.

Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma

Varalee Yodsurang, Thananya Inthanachai, K. Suppipat, 2024, Cancer immunology, immunotherapy : CII.